PortF.K., HeldP.J., NolphK.D., TurenneM.N., WolfeR.A.Risk of peritonitis and technique failure by CAPD connection technique: A national study.Kidney Int.1992; 42: 967–74.
2.
KuizonB.D., GoodmanW.G., JüppnerH., BoechatI., N el sonP., GalesB.Diminished linear growth during treatment with intermittent calcitriol and dialysis in children with chronic renal failure.Kidney Int.1998; 53: 205–11.
3.
RinaldiS., SeraF., VerrinaE., EdefontiA., PerfumoF., SorinoP.The Italian registry of pediatric chronic peritoneal dialysis: A ten-year experience with chronic peritoneal dialysis catheters.Perit Dial Int.1998; 18: 71–4.
4.
SaluskyI.B., FineR.N., NelsonP., BlumenkrantzM.J., KoppleJ.D.Nutritional status of children undergoing continuous ambulatory peritoneal dialysis.Am J Clin Nutr.1983; 38: 599–611.
CanepaA., PerfumoF., CarreaA., GiallongoF., VerrinaE., CantaluppiA.Long-term effect of amino-acid dialysis solution in children on continuous ambulatory peritoneal dialysis.Pediatr Nephrol.1991; 5: 215–19.
7.
McSherryE., MorrisR.C.Attainment and maintenance of normal status with alkali therapy in infants and children with classic renal tubular acidosis (RTA).J Clin Invest.1978; 61: 509–27.
8.
ChallaA., KriegRJJr., ThabetM.A., VeldhuisJ.D., ChanJ.C.Metabolic acidosis inhibits growth hormone secretion in rats: Mechanism of growth retardation.Am J Physiol.1993; 265: E547–53.
9.
ChallaA., ChanW., KriegRJJr., ThabetM.A., LiuF., HintzR.L.Effect of metabolic acidosis on the expression of insulin-like growth factor and growth hormone receptor.Kidney Int.1993; 44: 1224–7.
10.
BrünggerM., HulterH.N., KrapfR.Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: New cause of growth hormone insensitivity in humans.Kidney Int.1997; 51: 216–21.
11.
SaluskyI.B., CoburnJ.W., BrillJ., FoleyJ., SlatopolskyE., FineR.N.Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.Kidney Int.1988; 33: 975–82.
12.
GoodmanW.G., SaluskyI.B.Evolution of secondary hyperparathyroidism during daily oral calcitriol therapy in pediatric renal osteodystrophy.Contrib Nephrol.1991; 90: 189–95.
13.
GoodmanW.G., RamirezJ.A., BelinT.R., ChonY., GalesB., SegreG.V.Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.Kidney Int.1994; 46: 1160–6.
14.
VortkampA., LeeK., LanskeB., SegreG.V., KronenbergH.M., TabinC.J.Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein.Science.1996; 273: 613–22.
15.
SanchezC.P., SaluskyI.B., KuizonB.D., WillseyP., JüppnerH., GoodmanW.G.Endochondral bone formation in rats with renal failure: Modulation by secondary hyperparathyroidism, growth hormone and calcitriol.Kidney Int.1998; 54: 1879–87.
16.
BagdadeJ.D., CasarettoA., AlbersJ.Effects of chronic uremia, hemodialysis, and renal transplantation on lipids and lipoproteins in man.J Lab Clin Med.1976; 87: 37–48.
17.
PapadopoulouZ.L., SandlerP., TinaL.U., JoseP.A., CalcagnoP.L.Hyperlipidemia in children with chronic renal insufficiency.Pediatr Res.1981; 15: 887–9.
18.
QuerfeldU., LeBoeufR., SaluskyI.B., NelsonP., LaidlawS., FineR.N.Lipoproteins in children treated with continuous peritoneal dialysis.Pediatr Res.1991; 29: 155–9.
19.
LindholmB., BergströmJ., NorbeckH.E.Lipoprotein (LP) metabolism in patients on continuous ambulatory peritoneal dialysis (CAPD). In: GahlG.M., KesselM., NolphK.D., eds. Advances in Peritoneal Dialysis.Amsterdam: Excerpta Medica; 1981: 434–6.
20.
RamosJ.M., HeatonA., McGurkJ.G., WardM.K., KerrD.N.S.Sequential changes in serum lipids and their subfractions in patients receiving continuous ambulatory peritoneal dialysis.Nephron.1983; 35: 20–3.
